Publicaciones en colaboración con investigadores/as de Universitat de les Illes Balears (56)

2023

  1. Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay

    Pharmacological Reports, Vol. 75, Núm. 2, pp. 266-275

  2. Regulation of Cortico-Thalamic JNK1/2 and ERK1/2 MAPKs and Apoptosis-Related Signaling Pathways in PDYN Gene-Deficient Mice Following Acute and Chronic Mild Stress

    International journal of molecular sciences, Vol. 24, Núm. 3

2021

  1. 5-HT2A receptor- and M1 muscarinic acetylcholine receptor-mediated activation of Gαq/11 in postmortem dorsolateral prefrontal cortex of opiate addicts

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1155-1163

  2. 5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study

    World Journal of Biological Psychiatry, Vol. 22, Núm. 7, pp. 505-515

  3. Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 222

  4. Effects of Gαi2 and Gαz protein knockdown on alpha2A-adrenergic and cannabinoid CB1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1122-1135

2020

  1. Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease

    Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633

  2. Functional coupling of M1 muscarinic acetylcholine receptor to Gαq/11 in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 270, Núm. 7, pp. 869-880

2019

  1. Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice

    Neurotherapeutics, Vol. 16, Núm. 2, pp. 416-431

  2. Optimization and pharmacological characterization of receptor-mediated Gi/o activation in postmortem human prefrontal cortex

    Basic and Clinical Pharmacology and Toxicology, Vol. 124, Núm. 6, pp. 649-659

2018

  1. Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay

    Purinergic Signalling, Vol. 14, Núm. 2, pp. 177-190

2017

  1. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample

    Molecular Neurodegeneration, Vol. 12, Núm. 1

  2. Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes

    Journal of Neural Transmission, Vol. 124, Núm. 9, pp. 1123-1133

  3. Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I2 Receptor Ligands

    ACS Chemical Neuroscience, Vol. 8, Núm. 4, pp. 737-742

2016

  1. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

    World Journal of Biological Psychiatry, Vol. 17, Núm. 4, pp. 308-315

2015

  1. Adenosine A1 receptors are selectively coupled to Gαi-3 in postmortem human brain cortex: Guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding/immunoprecipitation study

    European Journal of Pharmacology, Vol. 764, pp. 592-598

  2. Up-regulated 14-3-3β and 14-3-3ζ proteins in prefrontal cortex of subjects with schizophrenia: Effect of psychotropic treatment

    Schizophrenia Research, Vol. 161, Núm. 2-3, pp. 446-451

2014

  1. FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments

    Neuroscience, Vol. 277, pp. 541-551

  2. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment

    Journal of Affective Disorders, Vol. 167, pp. 343-350

2013

  1. Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment

    Psychopharmacology, Vol. 226, Núm. 1, pp. 177-188